All Products
  • Antibiotics
    • Penicillins
    • Cephalosporins
    • Macrolides
    • Other Antibiotics
  • Central Nervous System
    • Others
    • Analgesics & Antipyretics
    • Non-steroidal anti-inflammatory drugs
  • Musculoskeletal system
  • Respiratory System
    • Cough & Cold Preparations
  • Allergy & Immune System
    • Histamin
  • Gastrointestinal System
  • Cardiovascular System
  • Corticosteroid Hormones
  • Herbal Medicines
  • Health Supplements
    • Nutrition & Release Body Heat
    • Support & Detoxify the Liver
    • Support Brain Function & Sedatives
    • Support Kidney Function & Improve Male Sexual Frigidity
    • Antioxidant, Inhibit the Free Radicals
    • Antidiabetic Agents
    • Gastrointestinal System
    • Cough & Cold
    • Skeletal - Joints
  • Oral Antidiabetic Agents
  • Vitamins & Minerals

Hotline

0273 3872 972

VN
ABOUT US
Overview
History
Mission & Vision
Organization Structure
MEDIA
News
Library
Careers
INVESTOR RELATIONS
Tipharco Shares Information
Disclosure
Financial Statements
General Shareholders Meeting
Corporate Governance
Annual Reports
Newsletters
Event Calendar
Contacts
INVOICE SEARCH
All products
Antibiotics
Penicillins Cephalosporins Macrolides Other Antibiotics
Central Nervous System
Others Analgesics & Antipyretics Non-steroidal anti-inflammatory drugs
Musculoskeletal system
Respiratory System
Cough & Cold Preparations
Allergy & Immune System
Histamin
Gastrointestinal System
Cardiovascular System
Corticosteroid Hormones
Herbal Medicines
Health Supplements
Nutrition & Release Body Heat Support & Detoxify the Liver Support Brain Function & Sedatives Support Kidney Function & Improve Male Sexual Frigidity Antioxidant, Inhibit the Free Radicals Antidiabetic Agents Gastrointestinal System Cough & Cold Skeletal - Joints
Oral Antidiabetic Agents
Vitamins & Minerals

  1. Home
  2. INVESTOR RELATIONS
  3. Disclosure
  4. 2022

Disclosure

2025
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
  • Republish Resolution of the Board of Directors on the implementation of the plan of follow-on public offer to existing shareholders 10/13/2022
  • Resolution of the Board of Directors on the implementation of the plan of follow-on public offer to existing shareholders 10/11/2022
  • Resolution of the Board of Directors on the termination of operation of To Hien Thanh - Ho Chi Minh City branch 10/05/2022
  • Notice of Tipharco has receipt Ms. Huynh Vu Khanh Vy's resignation letter from position of a member of the Supervisory Board 10/03/2022
  • Resolution of the Board of Directors on the receipt of the resignation of the Head of the Supervisory Board 09/21/2022
  • Notice of Tipharco has signed the contract with the audit unit for auditing 2022 financial statements 09/19/2022
  • Notice about the selection of the unit to audit the financial statements in 2022 08/04/2022
  • Report on results of transaction in shares of internal person and affiliated person - Bamboo Capital 07/29/2022
  • Notice of transaction in shares of internal person and affiliated person of internal person - Bamboo Capital Group 07/13/2022
  • Report on the day ceasing to be major shareholders, investors owning 5% or more of shares - Ms. Ho Thi Thuy Dung 07/13/2022
  • Notice of change of Business Registration Certificate 07/08/2022
  • Report on the day becoming to be major shareholders, investors owning 5% or more of shares 07/07/2022
  • Minutes and Resolutions for collecting written shareholder opinions March 6, 2022 06/27/2022
  • Report on ownership changes of major shareholders - Ms. Nguyen Phuong Hoa 06/21/2022
  • Notice on the update of the written shareholder opinion document 06/13/2022
  • Notice on the correction of the written shareholder opinion document 06/13/2022
  • Report on the day becoming to be major shareholders, investors owning 5% or more of shares - Ms. Nguyen Phuong Hoa 06/13/2022
  • Written shareholder opinion document March 6, 2022 06/10/2022
  • Report on the day ceasing to be major shareholders, investors owning 5% or more of shares - Thien Khanh Pharmacitical Co., Ltd. 06/10/2022
  • Notice of the record date to collect written shareholder opinions 05/06/2022
  • 1
  • 2
  • 3
  • ›
  • »
  • Tipharco Shares Information
  • Disclosure
  • Financial Statements
  • General Shareholders Meeting
  • Corporate Governance
  • Annual Reports
  • Newsletters
  • Event Calendar

Tipharco Pharmaceutical Joint Stock Company (“Tipharco”) was established in 1976 and is currently on UPCOM (Stock code: DTG) since 2017. Tipharco has 3 pharmaceutical factories: non-Beta-lactam, Beta-lactam, and herbal medicine factories that meet GMP-WHO standards.

CONTACTS
Address: No.26 Street 40, Thao Dien Ward, Thu Duc City, Hochiminh City
Factory: Lot 08, 09, Tan My Chanh Small Industrial and Handicraft Cluster, Ward 9, My Tho City, Tien Giang Province, Vietnam

Telephone: 0273.3872.972

Fax: 0273.3885.040

Email: info@tipharco.vn
  • Overview
  • News
  • Careers
  • Contacts

Công ty Cổ Phẩn

Dược Phẩm Tipharco

Giấy CNĐKDN số:1200100557

  • Antibiotics
  • Analgesics & Antipyretics
  • Non-steroidal anti-inflammatory drugs
  • Respiratory System
  • Allergy & Immune System
  • Gastrointestinal System
  • Cardiovascular System
  • Corticosteroid Hormones
  • Herbal Medicines
  • Support & Detoxify the Liver
  • Antidiabetic Agents
  • Cough & Cold
  • Oral Antidiabetic Agents
Copyright © 2022 Tipharco.. All rights reserved